Asian Annals Click here to go to Maquet website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Sha Liu
Ming Di Xiao
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, S.
Right arrow Articles by Xiao, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, S.
Right arrow Articles by Xiao, M. D.
Related Collections
Right arrow Cardiac - other
Asian Cardiovasc Thorac Ann 2002;10:8-11
© 2002 Asia Publishing EXchange Pte Ltd


ORIGINAL CONTRIBUTION

Cardiac Myxoma and Myxosarcoma: Clinical Experience and Immunohistochemistry

Liu Sha, MD, Wang Zhe, MD1, Chen An Qing, MD1, Zhou Guang Hua, MD1, Jiang Zhen Bin, MD1, Xiao Ming Di, MD

Department of Cardiovascular Surgery Shanghai First People's Hospital Shanghai, People's Republic of China
1 Department of Cardiovascular Surgery Shanghai Institute of Cardiovascular Diseases Fudan University Zhongshan Hospital Shanghai, People's Republic of China
Liu Sha, MD Tel: 86 21 6324 0090 Ext. 3031 Fax: 86 21 6324 0825 email: drliusha{at}yahoo.com Department of Cardiovascular Surgery, Shanghai First People's Hospital, 85 Wujin Road, Shanghai 200080, People's Republic of China.
From January 1978 to February 1999, 120 patients (42 males and 78 females) with cardiac myxoma (115) or myxosarcoma (5) underwent surgical excision or biopsy. There were 5 early postoperative deaths (mortality, 4.2%). Seventy-three survivors were followed up for 0.75 to 20.25 years (mean, 9.42 years); they comprised 4 myxosarcoma patients who all had recurrence or metastasis, and 69 myxoma patients who had no evidence of recurrence or metastasis. Neither familial myxoma nor Carney complex was found. The 5 cases of myxosarcoma and 18 randomly selected cases of myxoma were evaluated for proliferative activity, metastatic potential, and oncogene products by immunohistochemistry. The expression of p53 and Bcl-2 was similar in both groups. Overexpression of proliferating cell nuclear antigen and low expression of nm23 in myxosarcoma are consistent with the high rate of recurrence and metastasis of this tumor. Surgical resection of sporadic myxoma is a safe and effective treatment with satisfactory early and long-term results. However, the prognosis of myxosarcoma is still disappointing. Regular echocardiography and chest radiography or computed tomography are necessary for early detection of recurrence or metastasis of myxosarcoma.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by the Asia Publishing EXchange Ltd.